MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.

2022-09-15

International Pain Awareness Month: Spotlight on Chronic Pain Management

September is International Pain Awareness month. This month we highlight the importance of a multidisciplinary and individualized approach to pain management.

What is Chronic Pain?

Chronic pain is pain that continues or recurs for more than three months. Chronic pain may be either primary (not attributed to another diagnosis) or secondary (a symptom of an underlying health condition). Although it may be seen as a symptom, the World Health Organization recognizes chronic pain as a disease in its own right in the eleventh version of the International Statistical Classification of Diseases and Related Health Problems, which came into effect in 2022.

Why is it Important?

The Canadian Pain Task Force describes chronic pain as “a public health emergency in need of action.” As of 2019, an estimated 7.6 million people across Canada – one in five Canadians – were living with chronic pain. As a result of population growth and aging, that number is expected to reach as many as 9 million Canadians by 2030 – an increase of 17.5 percent.

Chronic pain negatively affects patients’ lives in many ways:

    • decreased

quality of life

Chronic pain also has a significant economic impact. Health Canada estimates that in 2019 alone, the combined direct and indirect cost of chronic pain was between $38.2 and $40.3 billion. In 2030, that number is estimated to grow to between $52 and $55 billion – a total increase of 36.2 percent from 2019.

Finally, the COVID-19 pandemic has led to increased pain and disability for people living with chronic pain, and has created disruptions in healthcare that have reduced access to support and treatments that help to maintain their quality of life.

Management of Chronic Pain

Evidence and clinical experience suggest that any approach to management of chronic pain should be individual, multimodal, and multidisciplinary.

An Individual Experience

Pain is subjective and multidimensional, incorporating sensory, emotional and cognitive components: where the pain is felt in the body, and the intensity of that sensation; the unpleasantness of the experience; and how a person interprets and reacts to the pain (for example, with fear or anxiety). Pain is also highly personal, influenced by a myriad of factors unique to each person. Pain is thus a profoundly individual experience. There is no “one size fits all” solution to management of chronic pain; instead, treatment should be tailored to each patient’s particular needs, experience, and circumstances.

Multimodal Intervention

Chronic pain is complex; a single intervention is rarely enough to reduce patients’ suffering and improve their quality of life. Instead, it is best addressed by a multimodal approach that takes into account the various aspects of the patient’s experience of chronic pain: physical, cognitive, psychological, and behavioural.

Treatments for chronic pain range from traditional and non-traditional pharmacotherapy through physiotherapy and psychological support to interventions such as intrathecal therapy, neurostimulation and radiofrequency ablation. Complementary and alternative medicine may also play a role.

A Multidisciplinary Team

The diverse facets of chronic pain suggest that patients should be treated by a multidisciplinary team. Patients are more likely to receive an accurate diagnosis and to benefit from interventions tailored to their particular needs. Such a team usually includes three physicians (for example, a primary care physician, an anesthesiologist or pain specialist, and a psychiatrist) and several other healthcare providers. The members of the larger team will vary according to the patient’s particular health condition and circumstances, and may include specialists, pharmacists, physiotherapists, dietitians, complementary therapists, occupational therapists and medical social workers.

The benefits of this approach include diagnosis of pain at an early stage, a wide range of treatments, the opportunity for the patient to discuss interventions with appropriate healthcare providers, and continuity of care. Research has consistently shown that multidisciplinary pain treatment leads to reduced pain intensity. Other benefits of this approach include improvement in physical function, quality of life, emotional stress, and behavioural outcomes.

Chronic pain in primary care

While the evidence shows that multidisciplinary pain clinics are clinically and economically effective, waiting lists are long (up to 18 months). As a result, primary care clinicians may find themselves taking on a lead role in pain care for patients with chronic pain.

Clinicians: Learn about the role of antispasmodics in managing the abdominal pain, cramping and discomfort of functional gastrointestinal disorders by taking this complimentary course.

Join MDBriefCase for free

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.

Audience and Appropriate Topics

The  Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.

Parameters

Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words. 

Review

MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement